Japan Researchers Develop Biosensor To Detect Disease Presence
This article was originally published in PharmAsia News
Japanese researchers say they have developed a biosensor that advances the capability of identifying disease-related proteins. The joint work conducted by the Tokyo Institute of Technology and Canon showed the device was able to detect the diseases from blood samples that determine whether a protein binds to antibodies. The researchers say their test requires only seconds to produce results. In theory, at least, the biosensor could detect the presence of a single molecule. (Click here for more - a subscription may be required
You may also be interested in...
Purdue’s opioid settlement is making headlines for the size of the financial penalty. But the plan to re-imagine Purdue as a ‘public benefit company’ could have far-reaching significance for the industry – if it ever gets off the ground.
Merck’s third quarter beat analyst consensus and the company raised its guidance. The COVID-19-battered vaccines business began to improve but Gardasil’s recovery was slower than expected.
Given concerns about completing Phase III trials, advisory committee member asks whether US FDA has considered ‘the possibility of an expanded access protocol,’ but agency official points to added complexity that comes with the pathway; bioethics experts talk to the Pink Sheet about pros and cons of expanded access vs. EUA pathways.